Catalyst Wire Dossier Catalyst Wire Dossier

Canfosfamide

canfosfamide · Telik
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Canfosfamide, covering 2013-03-15 to 2013-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma [Phase 2]

See pricing